New Release of Advarra’s Study Collaboration Solution Provides Sponsors and CROs a Single View into the Progress of Site Activation Milestones and IRB Review Status Across Sites
COLUMBIA, MD, April 17, 2025— Advarra, the market leader in regulatory reviews and clinical research technology, today announced the integration of its electronic institutional review board (eIRB) system, Center for IRB Intelligence (CIRBI®), with its Study Collaboration solution, a single-sign-on-enabled software that guides sites through the activation process and improves enrollment planning and tracking. This first-of-its-kind integration creates an automated link between IRB review status and clinical trial startup workflows, giving sponsors and CROs centralized visibility into the status of site activation—from site selection to first-patient-in (FPI).
Already, more than 14,000 sites worldwide rely on Advarra’s Study Collaboration solution to accelerate study startup activities such as feasibility assessments, document exchange and communication, and study training on sponsored trials. With the latest release of Study Collaboration, sponsors and CROs gain a single view into how their sites are progressing through each startup milestone, including IRB review status. As site staff complete each task in the solution, progress against milestones is automatically populated. The added transparency gives sponsors and CROs a more accurate picture of their study’s progress, while reducing manual tasks and redundant status checks for sites and study teams alike.
“With Advarra’s IRB services supporting over 60% of clinical trials in North America, we are uniquely positioned to provide sponsors and CROs with greater visibility into site activation,” said Ashley Davidson, Vice President, Product Lead of Sponsor Tech Strategy at Advarra. “By automating IRB review status updates and embedding them directly into Study Collaboration’s milestone tracking capabilities, we have replaced the need for spreadsheets and disconnected systems—empowering study teams to oversee every critical step as it happens and offer faster, more targeted support to sites preparing for enrollment. At the same time, these enhancements ease the administrative burden on sites by streamlining manual tasks and reducing redundant status checks.”
Mark Morais, President and COO of Clinical Development at Fortrea, added: “We are continuously improving the study startup process to reduce the administrative burden for sites and give sponsors better visibility into trial timelines. It’s encouraging to see Advarra launch enhancements to its study startup software that centralize visibility into the progress of startup milestones, eliminating the need for sites to manually track and report on their progress.”
Register for a Live Demo of the Latest Release
Join Advarra’s study startup experts for a live demo of the latest release of the Study Collaboration solution on Thursday, May 8, 2025 at 1:00 – 1:30 pm ET / 10:00 – 10:30 am PT. See how Advarra’s study startup and IRB technologies integrate to deliver better visibility within its milestone tracking capability. Register for the 30-minute live demo using this link: https://www.advarra.com/open-demo-ssu/.
About Advarra
Advarra breaks the silos that impede clinical research, aligning patients, sites, sponsors, and CROs in a connected ecosystem to accelerate trials. Advarra is number one in research review services, site and sponsor technology, and clinical trial experience software and is trusted by the top 50 global biopharma sponsors, top 20 CROs, and 50,000 site investigators worldwide. Advarra solutions enable collaboration, transparency, and speed needed to optimize trial operations, ensure patient safety and engagement, and reimagine clinical research while improving compliance. For more information, visit advarra.com.
Media Contact:
Lisa Barbadora
Barbadora INK for Advarra
+1 (610) 420-3413
lbarbadora@barbadoraink.com / mediarelations@advarra.com